ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Fibrinogen-to-Albumin Ratio and Long-Term Mortality in Coronary Artery Disease Patients with Different Glucose Metabolism Status

Xie, Yun; Xu, Xiayan; Wang, Dongmei; Zhou, Yang; Kang, Yu; Lai, Wenguang; Lu, Hongyu; Liu, Jin; Chen, Shiqun; Xu, Junyan; Yan, Xiaoming*; Huang, Xiaoyu*; Liu, Yong*广东省人民医院; 广东省心血管病研究所; 南方医科大学; 汕头大学; y
Reviews in Cardiovascular Medicine2023-11DOI: 10.31083/j.rcm2411317
8阅读
引用收藏
分享

摘要

Background: Abnormal glucose metabolism is present in most patients with coronary artery disease (CAD). Inflammation is considered to be a common risk factor for CAD and diabetes. Fibrinogen-to-albumin ratio (FAR), a novel inflammation biomarker, has been proposed as a predictor for cardiovascular disease. However, the relationship between the level of FAR and long-term mortality including all-cause, cardiovascular and cancer mortality, remains unknown in CAD patients, especially those with prediabetes. Methods: We enrolled 66,761 CAD patients from 2007 to 2020 from a multi-center registry cohort study. The primary outcomes were the all-cause, cardiovascular and cancer mortality. FAR was calculated using the following formula: Fibrinogen (g/L)/Albumin (g/L). Patients were divided into three groups by FAR tertile (low FAR (FAR-L), median FAR (FAR-M), high FAR (FAR-H)), and further categorized into 9 groups according to FAR and glucose metabolism status (normal glucose regulation (NGR), prediabetes mellitus (PreDM), diabetes mellitus (DM)). Cox regression models and competing risk models were used to examine the relationships between FAR and clinical outcomes. Results: 66,761 patients (63.1 +/- 11.0 years, 75.3% male) were enrolled. During the follow-up, 10,534 patients died, including 4991 cardiovascular deaths and 1092 cancer deaths. After adjusting for confounders, higher FAR was associated with increased risk of all -cause and cause-specific mortality in CAD patients with NGR, PreDM and DM. The risk of all-cause and cardiovascular mortality was highest in FAR-H with DM (HR (95% CI) = 1.71 (1.58-1.86), 2.11 (1.86-2.38), respectively; p < 0.001). FAR-H with PreDM was significantly associated with the highest risk of cancer mortality (HR (95% CI) = 2.27 (1.70-3.02), p < 0.001). Adding FAR to the original model significantly improved the prediction of long-term mortality. Conclusions: Increased FAR was significantly associated with higher risk of all-cause and cause-specific mortality in CAD patients with NGR, PreDM and DM. Abnormal glucose metabolism augments the relationship between FAR and mortality. Clinical Trial Registration: ClinicalTrials.gov NCT05050877.

学科与关键词

关键词
fibrinogen -to -albumin ratiodiabetesprediabeteslong-term mortalitycoronary artery disease
相关
加载中…
  • Association Between Systemic Immune Inflammation Level and Poor Prognosis Across Different Glucose Metabolism Status in Coronary Artery Disease Patients
    Xu, Xiayan; Xie, Yun; Gu, Xia; Zhou, Yang; Kang, Yu; Liu, Jin; Lai, Wenguang; Lu, Hongyu; Chen, Shiqun; Xu, Jun-yan; Lin, Feng*; Liu, Yong*Journal of Inflammation Research, 2023, 16: 4031-4042.
  • Hyperglycemia newly detected by glycated hemoglobin affects all-cause mortality in coronary artery disease patients: a retrospective cohort study
    Wei, Wen; Liang, Yan; Guo, Dachuan; Xu, Xinghao; Xu, Qingbo; Li, Shanggang; Li, Yuqi; Liu, Jin; Liu, Yong; Tu, Mei; Chen, Kaihong*; Chen, Hong*; Chen, Shiqun*Diabetes Research and Clinical Practice, 2022, 191: 110053.被引 3
  • The U-Shape Relationship Between Glycated Hemoglobin Level and Long-Term All-Cause Mortality Among Patients With Coronary Artery Disease
    Liu, Liwei; Ye, Jianfeng; Ying, Ming; Li, Qiang; Chen, Shiqun; Wang, Bo; Lin, Yihang; Chen, Guanzhong; Lun, Zhubin; Huang, Haozhang; Li, Huangqiang; Xu, Danyuan; Tan, Ning; Chen, Jiyan; Liu, Jin*; Liu, Yong*Frontiers in Cardiovascular Medicine, 2021, 8: 632704.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Reviews in Cardiovascular Medicine
发表日期
2023-11
卷期
第 24 卷, 第 11 期
页码
317
DOI
10.31083/j.rcm2411317
语言
ENGLISH
成果收录
SCIE
资助标注
Guangdong Provincial science and technology project [2020B1111170011, DFJH2020026, DFJH201919, KJ022021049]; National Science Foundation for Young Scientist of China [82070360]

作者

  • X

    Xie, Yun (第一作者)

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • X

    Xu, Xiayan

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

查看全部 13 位作者收起作者
  • W

    Wang, Dongmei

    guangdong prov peoples hosp

  • Z

    Zhou, Yang

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • K

    Kang, Yu

    shantou univ · guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • L

    Lai, Wenguang

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • L

    Lu, Hongyu

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • L

    Liu, Jin

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • C

    Chen, Shiqun

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • X

    Xu, Junyan

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • Y

    Yan, Xiaoming (通讯)

    guangdong prov peoples hosp · southern med univ

  • H

    Huang, Xiaoyu (通讯)

  • L

    Liu, Yong (通讯)

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417